Impact of pegloticase on patient outcomes in refractory gout: current perspectives
Rita N Cunha,1 Renata Aguiar,1 Filipa Farinha2 1Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal; 2Centre for Rheumatology, University College London, London, UK Abstract: Gout is currently the most frequent cause of inflammatory arthritis worldwide and is responsible for...
Guardado en:
Autores principales: | Cunha RN, Aguiar R, Farinha F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f364a6f388248df917e019a1dfdccbb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
por: J. Chen, et al.
Publicado: (2021) -
SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout
por: Jasvinder A. Singh, et al.
Publicado: (2021) -
Critical appraisal of the role of pegloticase in the management of gout
por: Ea HK, et al.
Publicado: (2012) -
Contentious Issues in Gout Management: The Story so Far
por: Talaat M, et al.
Publicado: (2021) -
Atypical musculoskeletal manifestations of gout in hyperuricemia patients
por: Sakti M, et al.
Publicado: (2019)